In Support of Breast-/Chestfeeding by People With HIV in High-Income Settings

Given that HIV can be transmitted through breastfeeding, historically, breastfeeding among women with HIV in the US and other resource-rich settings was discouraged. Formula feeding was the mandated feeding option out of concern for breast-milk transmission of HIV, which occurred in 16–24% of cases pre-antiretroviral therapy (pre-ART) use. In January 2023, the US Department of Health and Human Services’ Perinatal Guidelines were revised to support shared decision-making for infant feeding choices. Updated clinical trials’ data from resource-limited settings suggest the actual breastmilk HIV transmission rate in the context of maternal ART or neonatal postexposure prophylaxis is 0.3–1%. High-income countries are reporting more people with HIV breastfeeding their infants without cases of HIV transmission. We present the reasons for fully embracing breast-/chestfeeding as a viable, safe infant feeding option for HIV-exposed infants in high-income settings, while acknowledging unanswered questions and the need to continually craft more nuanced clinical guidance.